Covid-19: Vaccine as good in 'real world' as in trial in Israel
More data from Israel's vaccination program is suggesting the Pfizer jab prevents 94% of symptomatic infections.
More data from Israel's vaccination program is suggesting the Pfizer jab prevents 94% of symptomatic infections.